PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Calcipotriol
Presentation Product Chemical substance Chapter Items dispensed
Enstilar 50micrograms/g / 0.5 mg/g cutaneous foam
1305020D0BEAAAI
Enstilar Calcipotriol Skin 88,126
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% oint
1305020D0AAAFAF
Calcipotriol Calcipotriol Skin 51,722
Calcipotriol 50micrograms/g ointment
1305020D0AAAAAA
Calcipotriol Calcipotriol Skin 36,104
Calcipotriol 50microg/Betamethasone diprop 500microg/g foam
1305020D0AAAIAI
Calcipotriol Calcipotriol Skin 33,788
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% gel
1305020D0AAAGAG
Calcipotriol Calcipotriol Skin 31,606
Dovobet ointment
1305020D0BCAAAF
Dovobet Calcipotriol Skin 25,155
Dovobet gel
1305020D0BCABAG
Dovobet Calcipotriol Skin 24,210
Dovonex 50micrograms/g ointment
1305020D0BBAAAA
Dovonex Calcipotriol Skin 15,600
Calcipotriol 50micrograms/ml scalp solution
1305020D0AAACAC
Calcipotriol Calcipotriol Skin 6,540
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% cream
1305020D0AAAJAJ
Calcipotriol Calcipotriol Skin 1,374
Wynzora 50micrograms/g / 0.5mg/g cream
1305020D0BHAAAJ
Wynzora Calcipotriol Skin 1,315
Dovobet gel Applicator
1305020D0BCACAG
Dovobet Calcipotriol Skin 206
Dalonev ointment
1305020D0BFAAAF
Dalonev Calcipotriol Skin 104
Dalbecal 50micrograms/g / 0.5mg/g ointment
1305020D0BGAAAF
Dalbecal Calcipotriol Skin 48
Calcipotriol 50micrograms/g cream
1305020D0AAABAB
Calcipotriol Calcipotriol Skin 2
Dovonex 50micrograms/g cream
1305020D0BBABAB
Dovonex Calcipotriol Skin 1
Calcipotriol 50micrograms/g oint 50% in White soft paraffin
1305020D0AAAHAH
Calcipotriol Calcipotriol Skin No data available
Dovonex 50micrograms/ml scalp solution
1305020D0BBACAC
Dovonex Calcipotriol Skin No data available
Xamiol gel
1305020D0BDAAAG
Xamiol Calcipotriol Skin No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.